Does detection of fumonisin B2 and B3 in urine indicate recent exposure?

Detection of fumonisin B2 (FB2) and fumonisin B3 (FB3) in urine is a validated scientific method for assessing recent dietary exposure to these mycotoxins, which primarily contaminate maize-based products.

Clinical and investigative evidence

Research across diverse global populations confirms that FB2 and FB3 are reliable biomarkers for monitoring mycotoxin intake. In studies involving high-exposure groups in regions like South Africa, Mexico, and Nigeria, advanced analytical techniques such as LC-MS/MS and UHPLC-MS/MS have demonstrated detection frequencies often exceeding 70%.

• Correlation with intake: Urinary concentrations of these biomarkers directly reflect dietary consumption levels. For instance, intervention studies have shown that reducing fumonisin levels in food (e.g., through traditional processing methods like nixtamalization) results in a measurable and corresponding decrease in urinary FB2 and FB3 concentrations.
• Detection sensitivity: Modern assays provide high sensitivity for these parent compounds, allowing for precise quantification even at lower exposure levels. While FB1 is the most abundant fumonisin, multi-biomarker assays consistently utilize FB2 and FB3 to provide a more comprehensive exposure profile.

Mechanistic explanations

The use of FB2 and FB3 as biomarkers is based on their pharmacokinetic profile after ingestion.

• Excretion as parent compounds: Unlike many toxins that undergo extensive metabolic transformation, FB2 and FB3 are excreted in the urine as intact parent compounds. This makes them direct indicators of the specific toxins ingested.
• Rapid clearance: Although human-specific elimination half-lives for FB2 and FB3 are not fully characterized, animal models (such as pigs) show extremely rapid serum clearance—often with half-lives of less than an hour. This rapid transit from ingestion to excretion confirms that their presence in urine signifies recent exposure (typically within the last 24 to 48 hours) rather than historical or long-term accumulation.

Bottom line

Detection of FB2 and FB3 in urine is a robust and scientifically supported indicator of recent dietary exposure to fumonisins. Their presence reflects immediate past consumption, making them essential tools for assessing mycotoxin risk in both clinical and epidemiological settings.